Literature DB >> 26358588

Draft Genome Sequence of a Bordetella pertussis Strain with the Virulence-Associated Allelic Variant ptxP3, Isolated in Italy.

A Anselmo1, G Buttinelli2, A Ciammaruconi1, F Midulla3, A Nicolai3, A Fortunato1, A Palozzi1, S Fillo1, F Lista1, P Stefanelli4.   

Abstract

Despite a universal immunization program, pertussis has persisted and resurged, and is of particular concern for infants in terms of morbidity and mortality. Here, we report the genome sequence of a Bordetella pertussis strain with the virulence-associated allelic variant ptxP3, isolated from a 45-day-old infant.
Copyright © 2015 Anselmo et al.

Entities:  

Year:  2015        PMID: 26358588      PMCID: PMC4566170          DOI: 10.1128/genomeA.00944-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pertussis (whooping cough) is the most common vaccine-preventable disease, and despite widespread vaccination, the circulation of Bordetella pertussis, the causative agent of pertussis, has increased in many countries (1–3). One of the hallmarks of the resurgence of pertussis is the presence of polymorphisms in the virulence-associated genes, including the ptx promoter (ptxP); ptxP3, a novel allele for the pertussis toxin promoter, increases pertussis toxin production and is thus considered the most virulent (4). It replaced almost completely ptxP1 among circulating strains and, together with the sequence analysis of other genes, is commonly evaluated for its genetic divergence from the vaccine strain (5). Here, the draft genome sequence of a B. pertussis strain, isolated from an unvaccinated 45-day-old infant, is reported. The infant coughed for 33 days with paroxysms, and presented apnea and cyanosis. The strain was isolated from nasopharyngeal aspirate and lab-confirmed by routine conventional methods (6, 7). In particular, it showed the allelic profiles for ptxA1, ptxP3, prn 2, and MLVA 26. Genomic DNA was extracted using the QIAamp DNA minikit (Qiagen, Hilden, Germany) from a culture grown on Charcoal Agar plates at 35°C. The library was prepared from the extracted genomic DNA using the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, USA), and a 2 × 300 nucleotide (nt) paired-end sequencing run was performed using the Illumina MiSeq platform. The reads were trimmed and de novo assembled using Abyss version 1.5.2 software (8). The assembly of 2,786,692 reads generated 299 contigs >500 nt with 235× coverage. The estimated genome size is 3.9 Mb, with a G+C content of 67.5%.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number LFUE00000000. The version described in this paper is the first version, LFUE01000000.
  8 in total

1.  Triplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis.

Authors:  Yinghua Xu; Yunqiang Xu; Qiming Hou; Ruifu Yang; Shumin Zhang
Journal:  APMIS       Date:  2010-09-01       Impact factor: 3.205

2.  ABySS: a parallel assembler for short read sequence data.

Authors:  Jared T Simpson; Kim Wong; Shaun D Jackman; Jacqueline E Schein; Steven J M Jones; Inanç Birol
Journal:  Genome Res       Date:  2009-02-27       Impact factor: 9.043

3.  Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

Authors:  Katherine E Bowden; Margaret M Williams; Pamela K Cassiday; Andrea Milton; Lucia Pawloski; Marsenia Harrison; Stacey W Martin; Sarah Meyer; Xuan Qin; Chas DeBolt; Azadeh Tasslimi; Nusrat Syed; Ronald Sorrell; Mike Tran; Brian Hiatt; Maria Lucia Tondella
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

4.  Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain.

Authors:  V Sizaire; M Garrido-Estepa; J Masa-Calles; M V Martinez de Aragon
Journal:  Euro Surveill       Date:  2014-08-14

5.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

Review 6.  Bordetella pertussis: why is it still circulating?

Authors:  Nicole Guiso
Journal:  J Infect       Date:  2013-10-05       Impact factor: 6.072

7.  Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis.

Authors:  Kate E Templeton; Sitha A Scheltinga; Anneke van der Zee; Bram M W Diederen; Alida M van Kruijssen; Herman Goossens; Ed Kuijper; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

8.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.